The Choice Is Reperfusion Therapy: But Which One?
Publication
, Journal Article
Henry, TD; Armstrong, PW
Published in: JACC Cardiovasc Interv
October 10, 2016
Duke Scholars
Published In
JACC Cardiovasc Interv
DOI
EISSN
1876-7605
Publication Date
October 10, 2016
Volume
9
Issue
19
Start / End Page
2021 / 2023
Location
United States
Related Subject Headings
- Treatment Outcome
- Thrombolytic Therapy
- Myocardial Reperfusion
- Myocardial Infarction
- Fibrinolytic Agents
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Henry, T. D., & Armstrong, P. W. (2016). The Choice Is Reperfusion Therapy: But Which One? JACC Cardiovasc Interv, 9(19), 2021–2023. https://doi.org/10.1016/j.jcin.2016.08.004
Henry, Timothy D., and Paul W. Armstrong. “The Choice Is Reperfusion Therapy: But Which One?” JACC Cardiovasc Interv 9, no. 19 (October 10, 2016): 2021–23. https://doi.org/10.1016/j.jcin.2016.08.004.
Henry TD, Armstrong PW. The Choice Is Reperfusion Therapy: But Which One? JACC Cardiovasc Interv. 2016 Oct 10;9(19):2021–3.
Henry, Timothy D., and Paul W. Armstrong. “The Choice Is Reperfusion Therapy: But Which One?” JACC Cardiovasc Interv, vol. 9, no. 19, Oct. 2016, pp. 2021–23. Pubmed, doi:10.1016/j.jcin.2016.08.004.
Henry TD, Armstrong PW. The Choice Is Reperfusion Therapy: But Which One? JACC Cardiovasc Interv. 2016 Oct 10;9(19):2021–2023.
Published In
JACC Cardiovasc Interv
DOI
EISSN
1876-7605
Publication Date
October 10, 2016
Volume
9
Issue
19
Start / End Page
2021 / 2023
Location
United States
Related Subject Headings
- Treatment Outcome
- Thrombolytic Therapy
- Myocardial Reperfusion
- Myocardial Infarction
- Fibrinolytic Agents
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology